Get the Stockscreener App
0.2069
2.07%
0.0042
Essa Pharma Inc stock is traded at $0.2069, with a volume of 2.27M.
It is up +2.07% in the last 24 hours and down -89.17% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$0.2027
Open:
$0.209
24h Volume:
2.27M
Relative Volume:
0.42
Market Cap:
$9.79M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-0.3233
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
+0.68%
1M Performance:
-89.17%
6M Performance:
-87.07%
1Y Performance:
-96.58%
1-Day Range:
$0.204
$0.2137
1-Week Range:
$0.1853
$0.2137
52-Week Range:
$0.1853
$6.9045
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.2069 | 9.59M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.30 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
596.56 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.54 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
728.47 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
339.88 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
ESSA Pharma Inc. stock trendline breakdownJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
When is the best time to exit ESSA Pharma Inc.July 2025 Trends & Fast Gaining Stock Strategy Reports - newser.com
Stock Report: What is ESSA Pharma Incs 5 year growth outlook2025 Buyback Activity & Real-Time Volume Surge Alerts - خودرو بانک
Will ESSA Pharma Inc benefit from sector rotationQuarterly Investment Review & Scalable Portfolio Growth Methods - خودرو بانک
ESSA Pharma Reschedules Special Meeting for Acquisition - MSN
ESSA Pharma Inc. stock trend forecastQuarterly Growth Report & Daily Oversold Stock Bounce Ideas - newser.com
Trading Recap: Is ESSA Pharma Inc benefiting from innovation trendsEarnings Summary Report & Precise Buy Zone Identification - خودرو بانک
Fed Meeting: What drives ESSA Pharma Inc.’s stock priceJuly 2025 Setups & Community Verified Trade Signals - خودرو بانک
Will breakout in ESSA Pharma Inc. lead to full recoveryJuly 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
Is it too late to sell ESSA Pharma Inc.Wall Street Watch & Intraday High Probability Alerts - newser.com
Is ESSA Pharma Inc. stock entering bullish territoryEarnings Recap Summary & Capital Efficiency Focused Ideas - newser.com
ESSA Pharma Announces $80M Capital Distribution - MSN
Essa Pharma (EPIX) Nosedives 66% Ahead of Business Shutdown - MSN
Aug Sectors: Is ESSA Pharma Inc stock heavily shortedWeekly Trade Review & High Conviction Trade Alerts - خودرو بانک
ESSA Pharma Inc. stock retracement – recovery analysis2025 Performance Recap & AI Powered Buy/Sell Recommendations - newser.com
Fundamentals Check: Can ESSA Pharma Inc. stock outperform in a bear marketIPO Watch & Stepwise Trade Execution Plans - خودرو بانک
Big Picture: Is ESSA Pharma Inc still a buy after recent gainsWeekly Earnings Recap & Daily Price Action Insights - خودرو بانک
How to manage a losing position in ESSA Pharma Inc.Weekly Trade Report & Capital Efficient Trading Techniques - newser.com
Aug Big Picture: Is ESSA Pharma Inc a good stock for dollar cost averagingWeekly Investment Summary & Daily Stock Momentum Reports - خودرو بانک
How institutional ownership impacts ESSA Pharma Inc. stockWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Using Ichimoku Cloud for ESSA Pharma Inc. technicalsMarket Performance Report & Fast Gain Swing Trade Alerts - newser.com
Can ESSA Pharma Inc. stock deliver consistent earnings growthEarnings Recap Report & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Is ESSA Pharma Inc. stock bottoming outTrade Performance Summary & Smart Swing Trading Techniques - Newser
How to build a custom watchlist for ESSA Pharma Inc.July 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Will ESSA Pharma Inc. see short term momentumPrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Does ESSA Pharma Inc. show high probability of reboundWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Has ESSA Pharma Inc. found a price floor2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
What MACD and RSI say about ESSA Pharma Inc.Wall Street Watch & Daily Stock Trend Watchlist - Newser
Is ESSA Pharma Inc. forming a bottoming baseWeekly Investment Summary & Fast Moving Trade Plans - Newser
Can swing trading help recover from ESSA Pharma Inc. lossesJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Visual analytics tools that track ESSA Pharma Inc. performanceEarnings Miss & High Conviction Buy Zone Alerts - Newser
Volatility clustering patterns for ESSA Pharma Inc.Market Performance Summary & Daily Entry Point Alerts - Newser
What recovery options are there for ESSA Pharma Inc.July 2025 Analyst Calls & Free Long-Term Investment Growth Plans - Newser
Using economic indicators to assess ESSA Pharma Inc. potentialJuly 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Identifying reversal signals in ESSA Pharma Inc.Layoff News & Smart Investment Allocation Insights - Newser
Published on: 2025-09-12 00:51:00 - Newser
Applying sector rotation models to ESSA Pharma Inc.Quarterly Portfolio Summary & Low Drawdown Trading Strategies - Newser
Can a trend reversal in ESSA Pharma Inc. lead to recoveryPortfolio Return Report & High Yield Equity Trading Tips - Newser
ESSA Pharma Inc. stock volume spike explainedJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Tick level data insight on ESSA Pharma Inc. volatility2025 Retail Activity & Real-Time Stock Entry Alerts - Newser
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Essa Pharma Inc Stock (EPIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| BIOTECH GROWTH N V | 10% Owner |
Nov 01 '24 |
Sale |
1.53 |
7,879,583 |
12,018,409 |
0 |
| Virsik Peter | Chief Operating Officer |
Oct 07 '24 |
Sale |
6.03 |
694 |
4,185 |
7,776 |
0.28%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):